Regulation of autophagy and chloroquine sensitivity by oncogenic RAS in vitro is context-dependent

Chloroquine (CQ) is an antimalarial drug and late-stage inhibitor of autophagy currently FDA-approved for use in the treatment of rheumatoid arthritis and other autoimmune diseases. Based primarily on its ability to inhibit autophagy, CQ and its derivative, hydroxychloroquine, are currently being in...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Michael J, Gamez, Graciela, Menke, Christina, Hernandez, Ariel, Thorburn, Jacqueline, Gidan, Freddi, Staskiewicz, Leah, Morgan, Shellie, Cummings, Christopher, Maycotte, Paola, Thorburn, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Basic Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198365/
https://www.ncbi.nlm.nih.gov/pubmed/25136801
http://dx.doi.org/10.4161/auto.32135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198365/
https://www.ncbi.nlm.nih.gov/pubmed/25136801
http://dx.doi.org/10.4161/auto.32135

Ejemplares similares